drugset / Trial / NCT00788372

An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain

NCT00788372

Phase 3 Completed 142 enrolled Janssen Pharmaceutical K.K.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of fentanyl one-day transdermal patch (JNS020QD, patch containing a drug that is put on the skin so the drug will enter the body through the skin) in participants with chronic (lasting a long time) pain.

Timeline

Start
2008-11
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 12.5 ug Topical

Indications